Search
Menu
Home
HTB
2024
May
May 2024
Contents
Conference reports
BHIVA Spring Conference (BHIVA 2024)
Antiretrovirals
Drug resistance or side effects might limit ART in up to 1 in 10 people living with HIV
Guidelines
Updated BHIVA guidelines on HIV-related opportunistic infections (2024)
mpox
New York continues mpox vaccine and health awareness campaign
Drug resistance
Two new webinars on global approaches to integrase inhibitor drug resistance
COVID-19
No correlation between nasal viral load and severity of COVID-19 in large vaccine studies
HTB RSS
Early access
Closed clinics and limited ART in Zimbabwe, PEPFAR and UNAIDS news
4 May 2025
The RIO study: Q&A about controlling HIV with bNAbs
21 April 2025
Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years
20 April 2025
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs
13 April 2025
All early access reports
Current issues
May 2025
April 2025
March 2025
Back issues
Special report
Reduced dosing: a possible crisis response to ART stock-outs and closed clinics
5 May 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate